Abbott India (ABBOTINDIA) | Stock Overview & Key Data
Abbott India Performance Comparison
Stock Range
Today's Range
Low: ₹32,600.00
High: ₹32,990.00
on August 8, 2025
52 Week Range
Low: ₹25,325.00
High: ₹37,000.00
on January 29, 2025
on June 27, 2025
All-Time High: ₹37,000.00 on June 27, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR695.5B
EPS
665.14
P/E Ratio (TTM)
49.19
Forward P/E
39.06
P/B Ratio
16.42
PEG Ratio
2.77
Div. Yield
1.41%
ROE
35.66%
Beta
0.086
Debt to Equity
4.65
Financial Highlights
Profitability
Gross Margin
46.66%
Operating Margin
25.80%
Profit Margin
22.07%
Returns and Earnings
Return on Assets (TTM)
18.29%
Return on Equity (TTM)
35.66%
EBITDA
INR19.7B
Net Income (TTM)
INR14.1B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR3,016.17
Quarterly Revenue Growth (YoY)
11.50%
Quarterly Earnings Growth (YoY)
27.90%
Dividend Information
Last 12-Month Dividend
₹475.00
Current Dividend Yield
1.41%
3-Year Average Dividend Yield
0.99%
3-Year Average Annual Dividend
₹451.67
3-Year Total Dividends
₹1,355.00
Ex-Dividend Date
July 25, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Abbott India ABBOTINDIA | 695.47B Large-cap | -4.90% | -5.12% | 7.83% | 9.80% | 8.99% | 20.17% | 74.10% | 98.68% |
| Sun Pharmaceutical SUNPHARMA | 3.92T Large-cap | -6.35% | -4.85% | -10.27% | -8.65% | -15.43% | -8.07% | 74.63% | 200.22% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | -7.04% | -10.99% | -0.27% | -0.15% | 0.96% | 26.95% | 64.55% | 98.44% |
| Cipla CIPLA | 1.20T Large-cap | -4.09% | -1.29% | -1.18% | 1.27% | 0.78% | 3.58% | 45.16% | 93.18% |
| Torrent TORNTPHARM | 1.22T Large-cap | -3.88% | 7.29% | 9.29% | 10.38% | 5.21% | 5.56% | 128.85% | 24.13% |
| Mankind Pharma MANKIND | 1.08T Large-cap | -1.15% | 5.29% | 4.33% | 0.76% | -11.91% | 19.66% | 83.31% | 83.31% |
Ownership & Short Interest
Insider Ownership
75.51%
Institutional Ownership
7.85%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
7K
Average 90-Day Volume
9K
Abbott India Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Abbott India would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ABBOTINDIA's 52-week high and low?
- In the last 52 weeks, Abbott India reached a high of ₹37,000.00 (on June 27, 2025) and a low of ₹25,325.00 (on January 29, 2025).
- What is the market cap and P/E ratio for ABBOTINDIA?
- Curious about Abbott India's size and valuation? Its market capitalization stands at 695.47B. When it comes to valuation, the P/E ratio (trailing twelve months) is 49.19, and the forward P/E (looking ahead) is 39.06.
- Does ABBOTINDIA pay dividends? If so, what's the yield?
- Yes, Abbott India is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.41%, and the company has paid an average of ₹451.67 per share annually over the past 3 years.
- Who are Abbott India's main competitors or similar companies to consider before investing?
When looking at Abbott India, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.92T Healthcare Drug Manufacturers - Specialty & Generic -8.07% 74.63% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 26.95% 64.55% Cipla
CIPLA1.20T Healthcare Drug Manufacturers - Specialty & Generic 3.58% 45.16% Torrent
TORNTPHARM1.22T Healthcare Drug Manufacturers - Specialty & Generic 5.56% 128.85% Mankind Pharma
MANKIND1.08T Healthcare Drug Manufacturers - Specialty & Generic 19.66% 83.31% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Abbott India Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Abbott India's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 35.66%, the Debt to Equity ratio from the most recent quarter is 4.65, and its Gross Profit Margin stands at 46.66%.
- What is the recent revenue and earnings growth for ABBOTINDIA?
- Looking at Abbott India's growth, its revenue over the trailing twelve months (TTM) was INR64B. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.50%, and quarterly earnings saw a YoY growth of 27.90%.
- How much of ABBOTINDIA stock is held by insiders and institutions?
- Wondering who owns Abbott India stock? Company insiders (like executives and directors) hold about 75.51% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 7.85%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.